A research study of the role of artesunate in the treatment of Fasciola hepatica

Completed

• Conditions: Infections and Infestations; Fasciola hepatica; Liver fluke infection

• Registration Number: ISRCTN75869075
• Lead Sponsor: niversity of Oxford (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-03-16
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Either gender, aged greater than 8 years
2. Fasciola hepatica
3. Gives consent

Exclusion Criteria

Does not meet with inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical improvement in presenting complaint.

Secondary Outcome Measures

Name	Time	Method
1. Improvement in ultrasound appearance<br>2. Changes in eosinophilic count in peripheral blood<br>3. Biochemical parameters to return to normal<br>4. Haematology parameters return to normal<br>5. Absence of eggs in the stool